News

Aurinia selects Worldwide as its CRO for the AURORA study, a global trial of valcosporin for the treatment of lupus nephritis.

The international project, 1000 Genomes, is so far the world’s largest mapping of human genetic variants.

Funding will be used for feasibility study to investigate use of RNA extracted from urine for clinical diagnostic assays.

Novel genetic modifications may underlie the rapid wound healing and possibly higher resistance to cancers found in these ocean predators.

Artificial intelligence has been used to discover the exact interventions needed to obtain a specific, brand-new result in a living organism.

Discovery creates a new tool for studying L-2HG, a molecule commonly regarded as an "oncometabolite," which can promote tumor formation and growth.

Mapping the transcriptome of neurons with development will enable better understanding of brain function. Being able to target specific classes of interneurons will enable researchers to tease out their function and predict how these brain areas will respond to therapies.

The gene, known as NucS, has the ability to significantly reduce the rate of mutations in the TB genome.

Faster analysis should enable more effective corrective action, but the fundamental advantage with the sequence-based approach is avoiding the need for a specific test for each pathogen.

A mystery involving a mutant protein found 17 years ago has been solved. The protein pulled from roundworms, is now considered the earliest known actor in early cell division.